Glutamate controls tPA recycling by astrocytes, which in turn influences glutamatergic signals

Journal of Neuroscience

Volumn 32, Issue 15, 2012, Pages 5186-5199

  Cassé, Frédéric ^a   Bardou, Isabelle ^a,e   Danglot, Lydia ^b,c   Briens, Aurélien ^a   Montagne, Axel ^a   Parcq, Jérôme ^a   Alahari, Anuradha ^a,d   Galli, Thierry ^b,c   Vivien, Denis ^a   Docagne, Fabian ^a  

^a UNIVERSITÉ DE CAEN   (France)

^b INSERM   (France)

^c CNRS   (France)

^d Accent Medical and Scientific Writing   (France)

^e OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; KAINIC ACID RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; N METHYL DEXTRO ASPARTIC ACID; PROTEIN KINASE C; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; ENDOCYTOSIS; ENZYMATIC ASSAY; EXOCYTOSIS; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSFECTION; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; MOUSE; NERVE CELL; NEUROMODULATION; NEUROTOXICITY; NONHUMAN; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ZYMOGRAPHY;

EID: 84859534535     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5296-11.2012     Document Type: Article

References (50)

1. Araque A, Parpura V, Sanzgiri RP, Haydon PG (1998) Glutamatedependent astrocyte modulation of synaptic transmission between cultured hippocampal neurons. Eur J Neurosci 10:2129-2142.
2. Araque A, Li N, Doyle RT, Haydon PG (2000) SNARE protein-dependent glutamate release from astrocytes. J Neurosci 20:666-673.
3. Baranes D, Lederfein D, Huang YY, Chen M, Bailey CH, Kandel ER (1998) Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron 21:813-825.
4. Benchenane K, Berezowski V, Ali C, Fernández-Monreal M, López-Atalaya JP, Brillault J, Chuquet J, Nouvelot A, MacKenzie ET, Bu G, Cecchelli R, Touzani O, Vivien D (2005) Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptorrelated protein-mediated transcytosis. Circulation 111:2241-2249.
5. Bender AS, Norenberg MD (2000) Effect of ammonia on GABA uptake and release in cultured astrocytes. Neurochem Int 36:389-395.
6. Bergami M, Santi S, Formaggio E, Cagnoli C, Verderio C, Blum R, Berninger B, Matteoli M, Canossa M (2008) Uptake and recycling of pro-BDNF for transmitter-induced secretion by cortical astrocytes. J Cell Biol 183:213-221.
7. Bezzi P, Gundersen V, Galbete JL, Seifert G, Steinhäuser C, Pilati E, Volterra A (2004) Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate. Nat Neurosci 7:613-620.
8. Cao C, Lawrence DA, Li Y, Von Arnim CA, Herz J, Su EJ, Makarova A, Hyman BT, Strickland DK, Zhang L (2006) Endocytic receptor LRP together with tPA and PAI-1 coordinates Mac-1-dependent macrophage migration. EMBO J 25:1860-1870.
9. Chaineau M, Danglot L, Galli T (2009) Multiple roles of the vesicular-SNARE TI-VAMP in post-Golgi and endosomal trafficking. FEBS Lett 583:3817-3826.
10. Coco S, Calegari F, Pravettoni E, Pozzi D, Taverna E, Rosa P, Matteoli M, Verderio C (2003) Storage and release of ATP from astrocytes in culture. J Biol Chem 278:1354-1362.
11. Correa F, Gauberti M, Parcq J, Macrez R, Hommet Y, Obiang P, Hernangómez M, Montagne A, Liot G, Guaza C, Maubert E, Ali C, Vivien D, Docagne F (2011) Tissue plasminogen activator prevents white matter damage following stroke. J Exp Med 208:1229-1242.
12. Danglot L, Chaineau M, Dahan M, Gendron MC, Boggetto N, Perez F, Galli T (2010) Role of TI-VAMP and CD82 in EGFR cell-surface dynamics and signaling. J Cell Sci 123:723-735.
13. Fernández-Monreal M, López-Atalaya JP, Benchenane K, Léveillé F, Cacquevel M, Plawinski L, MacKenzie ET, Bu G, Buisson A, Vivien D (2004) Is tissue-type plasminogen activator a neuromodulator? Mol Cell Neurosci 25:594-601.
14. Galli T, Haucke V (2004) Cycling of synaptic vesicles: how far? How fast! Sci STKE 2004:re19.
15. Gveric D, Herrera BM, Cuzner ML (2005) tPA receptors and the fibrinolytic response in multiple sclerosis lesions. Am J Pathol 166:1143-1151.
16. Haydon PG, Carmignoto G (2006) Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev 86:1009-1031.
17. Kuiper J, Otter M, Voorschuur AH, van Zonneveld AJ, Rijken DC, van Berkel TJ (1995) Characterization of the interaction of a complex of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 with rat liver cells. Thromb Haemost 74:1298-1304.
18. Li D, Ropert N, Koulakoff A, Giaume C, Oheim M (2008) Lysosomes are the major vesicular compartment undergoing Ca2_-regulated exocytosis from cortical astrocytes. J Neurosci 28:7648-7658.
19. Lillis AP, Van Duyn LB, Murphy-Ullrich JE, Strickland DK (2008) LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol Rev 88:887-918.
20. Mallard F, Tang BL, Galli T, Tenza D, Saint-Pol A, Yue X, Antony C, Hong W, Goud B, Johannes L (2002) Early/recycling endosomes-to-TGN transport involves two SNARE complexes and a Rab6 isoform. J Cell Biol 156:653-664.
21. Martinez-Arca S, Alberts P, Zahraoui A, Louvard D, Galli T (2000) Role of tetanus neurotoxin insensitive vesicle-associated membrane protein (TIVAMP) in vesicular transport mediating neurite outgrowth. J Cell Biol 149:889-900.
22. McMahon HT, Ushkaryov YA, Edelmann L, Link E, Binz T, Niemann H, Jahn R, Südhof TC (1993) Cellubrevin is a ubiquitous tetanus-toxin substrate homologous to a putative synaptic vesicle fusion protein. Nature 364:346-349.
23. Mothet JP, Pollegioni L, Ouanounou G, Martineau M, Fossier P, Baux G (2005) Glutamate receptor activation triggers a calcium-dependent and SNARE protein-dependent release of the gliotransmitter D-serine. Proc Natl Acad Sci U S A 102:5606-5611.
24. Nagai T, Yamada K, Yoshimura M, Ishikawa K, Miyamoto Y, Hashimoto K, Noda Y, Nitta A, Nabeshima T (2004) The tissue plasminogen activatorplasmin system participates in the rewarding effect of morphine by regulating dopamine release. Proc Natl Acad Sci U S A 101:3650-3655.
25. Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET, Vivien D, Buisson A (2001) The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med 7:59-64.
26. Obiang P, Maubert E, Bardou I, Nicole O, Launay S, Bezin L, Vivien D, Agin V (2011) Enriched housing reverses age-associated impairment of cognitive functions and tPA-dependent maturation of BDNF. Neurobiol Learn Mem 96:121-129.
27. Pang PT, Teng HK, Zaitsev E, Woo NT, Sakata K, Zhen S, Teng KK, Yung WH, Hempstead BL, Lu B (2004) Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 306:487-491.
28. Pavlos NJ, Jahn R (2011) Distinct yet overlapping roles of Rab GTPases on synaptic vesicles. Small Gtpases 2:77-81.
29. Pawlak R, Magarinos AM, Melchor J, McEwen B, Strickland S (2003) Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior. Nat Neurosci 6:168-174.
30. Pellerin L, Magistretti PJ (1994) Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci U S A 91:10625-10629.
31. Qian Z, Gilbert ME, Colicos MA, Kandel ER, Kuhl D (1993) Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation. Nature 361:453-457.
32. Rajapakse S, Ogiwara K, Takano N, Moriyama A, Takahashi T (2005) Biochemical characterization of human kallikrein 8 and its possible involvement in the degradation of extracellular matrix proteins. FEBS Lett 579:6879-6884.
33. Rijken DC, Hoylaerts M, Collen D (1982) Fibrinolytic properties of onechain and two-chain human extrinsic (tissue-type) plasminogen activator. J Biol Chem 257:2920-2925.
34. Rodríguez-Moreno A, Lerma J (1998) Kainate receptor modulation of GABA release involves a metabotropic function. Neuron 20:1211-1218.
35. Samson AL, Medcalf RL (2006) Tissue-type plasminogen activator: a multifaceted modulator of neurotransmission and synaptic plasticity. Neuron 50:673-678.
36. Samson AL, Nevin ST, Croucher D, Niego B, Daniel PB, Weiss TW, Moreno E, Monard D, Lawrence DA, Medcalf RL (2008) Tissue-type plasminogen activator requires a co-receptor to enhanceNMDAreceptor function. J Neurochem 107:1091-1101.
37. Schiavo G, Benfenati F, Poulain B, Rossetto O, Polverino de Laureto P, Das-Gupta BR, Montecucco C (1992) Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359:832-835.
38. Schmid EM, McMahon HT (2007) Integrating molecular and network biology to decode endocytosis. Nature 448:883-888.
39. Seeds NW, Siconolfi LB, Haffke SP (1997) Neuronal extracellular proteases facilitate cell migration, axonal growth, and pathfinding. Cell Tissue Res 290:367-370.
40. Sheehan JJ, Zhou C, Gravanis I, Rogove AD, Wu YP, Bogenhagen DF, Tsirka SE (2007) Proteolytic activation of monocyte chemoattractant protein-1 by plasmin underlies excitotoxic neurodegeneration in mice. J Neurosci 27:1738-1745.
41. Sheng Z, Prorok M, Brown BE, Castellino FJ (2008) N-methyl-D-aspartate receptor inhibition by an apolipoprotein E-derived peptide relies on lowdensity lipoprotein receptor-associated protein. Neuropharmacology 55:204-214.
42. Siao CJ, Tsirka SE (2002) Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II. J Neurosci 22:3352-3358.
43. Su EJ, Fredriksson L, Geyer M, Folestad E, Cale J, Andrae J, Gao Y, Pietras K, Mann K, Yepes M, Strickland DK, Betsholtz C, Eriksson U, Lawrence DA (2008) Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 14:731-737.
44. Tsirka SE, Rogove AD, Bugge TH, Degen JL, Strickland S (1997) An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 17:543-552.
45. Volterra A, Meldolesi J (2005) Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 6:626-640.
46. Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SG, Lipton SA (1998) Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med 4:228-231.
47. Yasuda K, Itakura M, Aoyagi K, Sugaya T, Nagata E, Ihara H, Takahashi M (2011) PKC-dependent inhibition of CA2+-dependent exocytosis from astrocytes. Glia 59:143-151.
48. Yepes M, Sandkvist M, Moore EG, Bugge TH, Strickland DK, Lawrence DA (2003) Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Invest 112:1533-1540.
49. Zhang C, An J, Strickland DK, Yepes M (2009) The low-density lipoprotein receptor-related protein 1 mediates tissue-type plasminogen activatorinduced microglial activation in the ischemic brain. Am J Pathol 174:586-594.
50. Zhuo M, Holtzman DM, Li Y, Osaka H, DeMaro J, Jacquin M, Bu G (2000) Role of tissue plasminogen activator receptor LRP in hippocampal longterm potentiation. J Neurosci 20:542-549.